IP Library Patent Application 15943376
Patent Application
App. No. 15/943,376

INTRAGASTRIC SPACE FILLER

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/943,376
Abstract

A gastric space filler device for treating obesity in a patient by reducing the stomach volume comprising an inflatable space filler and a safety element secured to the space filler, wherein the safety element yields a noticeable signal for causing removal of the space filler.

Claims (28)

1 . A gastric space filler device for treating obesity in a patient by reducing the stomach volume comprising an inflatable space filler and a safety element secured to said space filler, wherein the safety element comprises a mechanism to yield a noticeable signal for causing a removal of said space filler.

2 . The gastric space filler device of claim 1 , wherein the safety element comprises a pressure sensor element for sensing an internal pressure of said inflatable space filler.

3 . The gastric space filler device of claim 3 , wherein the pressure sensor clement further comprises a transmitter for wirelessly transmitting the sensed internal pressure to a receiver outside a body of the patient.

4 . The gastric space filler device of claim 1 , wherein the safety element comprises a pH sensor element for sensing a pH of a stomach of the patient.

5 . The gastric space filler device of claim 5 , wherein the pH sensor element further comprises a transmitter for wirelessly transmitting the sensed pH to a receiver outside a body of the patient.

6 . The gastric space filler device of claim 1 , wherein the space filler and the safety element are configured to be in tandem or substantially parallel to each other inside a stomach pouch of the patient.

7 . The gastric space filler device of claim 1 , wherein the safety element is anchored to an inner wall of a stomach pouch of the patient.

8 . The gastric space filler device of claim 1 , wherein either the safety element or the space filler is ultrasonically visible.

9 . The gastric space filler device of claim 1 , wherein an ultrasonic transducer is provided for emitting an ultrasonic signal.

10 . The gastric space filler device of claim 1 , wherein the gastric space filler is configured to be deliverable through an esophagus of the patient.

11 . The gastric space filler device of claim 1 , wherein at least a portion of an external surface of the space filler device is treated with an anti-acid substance.

12 . The gastric space filler device of claim 1 , wherein at least a portion of an external surface of the space filler device is treated with a corrosion-resistant substance.

13 . The gastric space filler device of claim 1 , wherein at least a portion of an external surface of the space filler device is treated with an anti-adhesion substance.

14 . The gastric space filler device of claim 1 , wherein at least a portion of an external surface of the space filler device is treated with albumin or melatonin.

15 . The gastric space filler device of claim 1 , wherein at least a portion of an external surface of the space filler device is treated with phosphorylcholine.

16 . The gastric space filler device of claim 1 , wherein the space filler comprises a central opening extending therethrough.

17 . The gastric space filler device of claim 1 , wherein the space filler is sized to occupy at least 90% of a stomach volume of the patient.

18 . The gastric space filler device of claim 1 , wherein the space filler has an adjustable volume and is sized and configured to occupy up to 90% of a stomach volume of the patient.

19 . The gastric space filler device of claim 1 , wherein the space filler comprises a volume-adjusting mechanism for adjusting the space filler over time to allow initial acceptance by the stomach and increasing volume to get a right balance of weight loss and lack of nausea and vomiting.

20 . The gastric space filler device of claim 1 , wherein the safety element is an inflatable balloon made of a biodegradable material.

21 . The gastric space filler device of claim 20 , wherein the biodegradable material is selected from a group consisting of polymers or copolymers of lactide, glycolide, caprolactone, polydioxanone, trimethylene carbonate, polyorthoesters, and polyethylene oxide.

22 . The gastric space filler device of claim 20 , wherein the biodegradable material is selected from a group consisting of collagen, chitosan, elastin, gelatin, and combinations thereof.

23 . The gastric space filler device of claim 1 , wherein the space filler is made of a non-biodegradable material selected from a group consisting of polyester, polypropylene, Nylon, polyethylene, silicone, latex, polyethylene, and copolymers thereof.

24 . A gastric space filler device for treating obesity in a patient by reducing a stomach volume comprising an inflatable space filler with a first reference shape at an inflated state and means for substantially maintaining said first reference shape at a deflated state.

25 . The gastric space filler device of claim 24 , wherein the means for substantially maintaining said first reference shape at the deflated state is to provide a spiral supportive ridgeline onto said space filler.

26 . The gastric space filler device of claim 25 , wherein the spiral ridgeline comprises a material similar to material of the space filler.

27 . The gastric space filler device of claim 24 , wherein the means for substantially maintaining said first reference shape at the deflated state is to provide a plurality of cross bars inside an interior space of said space filler.

28 . A gastric space filler device for treating obesity in a patient by reducing a stomach volume comprising an inflatable space filler with a first cross-sectional circumference dimension at an inflated state and means for maintaining a second cross-sectional circumference dimension with at least 75 percentage of said first circumference dimension at a deflated state.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 23, 2019
From: RESHAPE LIFESCIENCES INC.
To: APOLLO ENDOSURGERY, INC.
Reel/Frame 050156/0236 →